US › Healthcare

Sunshine Biopharma Inc (SBFM)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.31+11.97%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$8.1M

Revenue YoY

-9.1%

Net profit

$-1.2M

Profit YoY

-5.4%

EPS

$-2.50

EPS estimate

$-1.60

Net margin

-15.4%

EPS came in at -2.50 against a street estimate of -1.60 — a miss of 56.2%.

Key statistics

Market cap

$2.8M

Forward P/E

0.0

P/B

0.13

Book value

$43.83

EPS (TTM)

$-12.50

52-week high

$24.30

52-week low

$1.10

50-day MA

$2.29

200-day MA

$10.12

Beta

1.31

Analyst view

Analysts rate Sunshine Biopharma Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $56.00.

Shareholding

Insiders

0.43%

Institutions

11.38%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	0.19%
TWO SIGMA SECURITIES, LLC	0.10%
XTX Topco Ltd	0.09%
Morgan Stanley - Brokerage Accounts	0.06%
SBI Securities Co Ltd	0.01%
UBS Group AG	0.00%
NATIONAL BANK OF CANADA /FI/	0.00%
Advisor Group Holdings, Inc.	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Sunshine Biopharma Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.